Ignite Creation Date:
2025-12-26 @ 11:11 AM
Ignite Modification Date:
2026-01-13 @ 9:02 AM
Study NCT ID:
NCT05098028
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2021-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients With Sickle Cell Disease
Sponsor:
Bausch Health Americas, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Sickle Cell Disease | View |
Keywords: